MedWatch

Convatec expects up to 5.5 percent growth in 2022

The annual report from British medtech firm Convatec has just been released, containing an organic growth guidance of 4–5.5 percent for 2022.

Photo: Convatec/PR

British medtech firm Convatec has released its annual report for 2021.

The report contained the company’s 2022 outlook, which is somewhat in line with analysts’ expectations, according to Bloomberg News, which collected the predictions prior to release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs